Breaking News Instant updates and real-time market news.

ACOR

Acorda Therapeutics

$23.55

2.5 (11.88%)

07:07
01/08/18
01/08
07:07
01/08/18
07:07

Acorda Therapeutics sees FY18 Ampyra net revenue $330M-$350M

AMPYRA net revenue is expected to be $330-$350 million. The Company expects to maintain exclusivity of AMPYRA at least through July 30, 2018; this guidance is subject to change based on the appellate court's decision. R&D expenses for the full year 2018 are expected to be $100-$110 million and include manufacturing expenses associated with INBRIJA. SG&A expenses for the full year 2018 are expected to be $170-$180 million. Year-end cash balance for 2018 is projected to be over $300 million.

  • 08

    Jan

  • 08

    Jan

ACOR Acorda Therapeutics
$23.55

2.5 (11.88%)

11/16/17
JANY
11/16/17
NO CHANGE
Target $17
JANY
Neutral
Acorda Therapeutics price target cut to $17 from $26 at Janney Capital
Janney Capital analyst Ken Trbovich lowered Acorda Therapeutics' price target to $17 from $26 following the company's announcement regarding adverse events related to Tozadenant. The analyst removed Tozadenant from his model and maintains a Neutral rating on shares.
11/20/17
LEER
11/20/17
NO CHANGE
LEER
Market Perform
Acorda discontinuation of Tozadenant a 'good strategic step,' says Leerink
Leerink analyst Paul Matteis points out that Acorda Therapeutics announced the discontinuation of Tozadenant development in Parkinson's disease in light of a recent safety update last week, noting a significant imbalance in agranulocytosis, sepsis and mortality on drug versus placebo. The analyst notes that he had removed tozadenant from his valuation based on his view that even if the drug had succeeded, these safety issues and related monitoring requirements would be too great of a cost in the context of a moderate symptomatic benefit. The discontinuation of Tozadenant should conserve some cash, he contends, adding that the company's decision is smart as the strategic focus fully shifts to CVT-301, also for Parkinson's Disease. Matteis reiterates a Market Perform rating on the shares.
11/21/17
JANY
11/21/17
NO CHANGE
Target $17
JANY
Neutral
Acorda could be worth $17-$27 in takeover, says Janney Capital
After Acorda Therapeutics announced that it is discontinuing development of tozadenant, an investigational treatment for Parkinson's disease, Janney Capital analyst Ken Trbovich said he believes a sale process appears necessary to protect shareholders from downside that he sees if Acorda remains independent. While the stock may only be worth $10-$11 if Acorda stays independent, it could be worth $17-$27 in a takeout scenario, estimated Trbovich, who maintains a Neutral rating and $17 fair value estimate on Acorda shares.
11/28/17
PIPR
11/28/17
INITIATION
Target $22
PIPR
Neutral
Acorda Therapeutics assumed with a Neutral at Piper Jaffray
Piper Jaffray analyst Charles Duncan assumed coverage of Acorda Therapeutics with a Neutral rating and $22 price target. The analyst believes Inbrija could be a best-in-class acute treatment with $800M in peak U.S. sales. He's looking for clinical and regulatory progress "which re-establishes conviction in Acorda's execution."

TODAY'S FREE FLY STORIES

HMNY

Helios and Matheson

$8.27

0.19 (2.35%)

14:45
01/23/18
01/23
14:45
01/23/18
14:45
Options
Helios and Matheson call volume above normal and directionally bullish »

Bullish option flow…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

MAT

Mattel

$16.09

-0.05 (-0.31%)

, HAS

Hasbro

$90.86

-1.7 (-1.84%)

14:42
01/23/18
01/23
14:42
01/23/18
14:42
Periodicals
Mattel gives CNN no comment on stock jump »

Paul La Monica of CNN…

MAT

Mattel

$16.09

-0.05 (-0.31%)

HAS

Hasbro

$90.86

-1.7 (-1.84%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 01

    Feb

  • 20

    Feb

  • 20

    Feb

AAPL

Apple

$177.00

-1.46 (-0.82%)

14:41
01/23/18
01/23
14:41
01/23/18
14:41
Recommendations
Apple analyst commentary  »

JPMorgan sees more signs…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 01

    Feb

GE

General Electric

$16.96

0.785 (4.85%)

14:30
01/23/18
01/23
14:30
01/23/18
14:30
Options
Heavy trading in GE as shares rally ahead of earnings »

Heavy trading in GE as…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Jan

SNE

Sony

$51.00

0.2 (0.39%)

, AAPL

Apple

$177.00

-1.46 (-0.82%)

14:25
01/23/18
01/23
14:25
01/23/18
14:25
Downgrade
Sony, Apple rating change  »

Sony downgraded to…

SNE

Sony

$51.00

0.2 (0.39%)

AAPL

Apple

$177.00

-1.46 (-0.82%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Jan

  • 01

    Feb

EXAS

Exact Sciences

$48.49

0.67 (1.40%)

14:25
01/23/18
01/23
14:25
01/23/18
14:25
Options
EXACT Sciences call volume above normal and directionally bullish »

Bullish option flow…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Feb

MAT

Mattel

$16.09

-0.05 (-0.31%)

, HAS

Hasbro

$90.86

-1.7 (-1.84%)

14:22
01/23/18
01/23
14:22
01/23/18
14:22
Hot Stocks
Breaking Hot Stocks news story on Mattel, Hasbro »

Mattel, Hasbro rally to…

MAT

Mattel

$16.09

-0.05 (-0.31%)

HAS

Hasbro

$90.86

-1.7 (-1.84%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 01

    Feb

  • 20

    Feb

  • 20

    Feb

FB

Facebook

$185.37

4.08 (2.25%)

14:18
01/23/18
01/23
14:18
01/23/18
14:18
Hot Stocks
Facebook CMO leaving to advise other companies, help Democratic Party »

In a status update, Gary…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Jan

  • 31

    Jan

  • 07

    Feb

  • 28

    Feb

$NSD

NASDAQ Market Internals

14:17
01/23/18
01/23
14:17
01/23/18
14:17
Technical Analysis
NASDAQ market internals summary »

Volume is average for…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

$NYE

NYSE Market Internals

14:16
01/23/18
01/23
14:16
01/23/18
14:16
Technical Analysis
NYSE market internals summary »

Volume is average for…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

W

Wayfair

$89.35

-1.29 (-1.42%)

14:15
01/23/18
01/23
14:15
01/23/18
14:15
Options
Wayfair put volume heavy and directionally bearish »

Bearish flow noted in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Feb

TWTR

Twitter

$22.84

-0.5 (-2.14%)

14:13
01/23/18
01/23
14:13
01/23/18
14:13
Recommendations
Twitter analyst commentary  »

Noto departure…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Jan

  • 07

    Feb

  • 08

    Feb

  • 28

    Feb

AAPL

Apple

$177.00

-1.46 (-0.82%)

14:10
01/23/18
01/23
14:10
01/23/18
14:10
Periodicals
KGI's Kuo says Apple's next iPhone to have no 3D touch, MacRumors reports »

Apple may launch a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 01

    Feb

SNE

Sony

$51.80

0.995 (1.96%)

14:10
01/23/18
01/23
14:10
01/23/18
14:10
Downgrade
Sony rating change  »

Sony downgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Jan

14:10
01/23/18
01/23
14:10
01/23/18
14:10
General news
U.S. equities cooled off from record highs »

U.S. equities cooled off…

BTC

Bitcoin

, BITCOIN

Bitcoin

14:09
01/23/18
01/23
14:09
01/23/18
14:09
Hot Stocks
Stripe says ending Bitcoin support »

Tom Karlo, Stripe's…

BTC

Bitcoin

BITCOIN

Bitcoin

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

REG

Regency Centers

$64.46

0.15 (0.23%)

14:08
01/23/18
01/23
14:08
01/23/18
14:08
Hot Stocks
Regency Centers acquires Whole Foods Market-anchored center in New Jersey »

Regency Centers …

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 09

    Feb

TEVA

Teva

$20.80

-0.22 (-1.05%)

, JNJ

Johnson & Johnson

$142.63

-5.51 (-3.72%)

14:06
01/23/18
01/23
14:06
01/23/18
14:06
Hot Stocks
NYC sues drug manufacturers, distributors over opioid epidemic »

New York City Mayor Bill…

TEVA

Teva

$20.80

-0.22 (-1.05%)

JNJ

Johnson & Johnson

$142.63

-5.51 (-3.72%)

ENDP

Endo

$7.31

0.2 (2.81%)

MCK

McKesson

$171.56

-1.405 (-0.81%)

CAH

Cardinal Health

$73.46

-0.05 (-0.07%)

ABC

AmerisourceBergen

$102.96

0.3 (0.29%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Jan

  • 24

    Jan

  • 01

    Feb

  • 06

    Feb

  • 08

    Feb

  • 16

    Feb

  • 08

    Mar

SHLD

Sears

$3.45

-0.18 (-4.96%)

14:05
01/23/18
01/23
14:05
01/23/18
14:05
Hot Stocks
Fitch downgrades Sears Holdings to 'C' on distressed debt exchange announcement »

Fitch Ratings has…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

FOLD

Amicus

$15.97

0.07 (0.44%)

14:05
01/23/18
01/23
14:05
01/23/18
14:05
Options
Amicus call volume above normal and directionally bullish »

Bullish option flow…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

NSC

Norfolk Southern

$150.81

-0.66 (-0.44%)

14:03
01/23/18
01/23
14:03
01/23/18
14:03
Hot Stocks
Breaking Hot Stocks news story on Norfolk Southern »

Norfolk Southern trading…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Jan

DIS

Disney

$110.10

-1 (-0.90%)

14:01
01/23/18
01/23
14:01
01/23/18
14:01
Hot Stocks
Disney to give over 125,000 employees one-time $1,000 cash bonus »

Disney chairman and CEO…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 06

    Feb

JNJ

Johnson & Johnson

$142.74

-5.4 (-3.65%)

14:00
01/23/18
01/23
14:00
01/23/18
14:00
Hot Stocks
Johnson & Johnson Remicade patent loss upheld on appeal »

The United States Court…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Jan

  • 16

    Feb

  • 08

    Mar

NVS

Novartis

$87.03

0.03 (0.03%)

, CMCSA

Comcast

$42.89

0.39 (0.92%)

13:59
01/23/18
01/23
13:59
01/23/18
13:59
Earnings
Notable companies reporting before tomorrow's open »

Notable companies…

NVS

Novartis

$87.03

0.03 (0.03%)

CMCSA

Comcast

$42.89

0.39 (0.92%)

GE

General Electric

$16.87

0.7034 (4.35%)

UTX

United Technologies

$135.42

0.2064 (0.15%)

ABT

Abbott

$59.32

-0.2501 (-0.42%)

GD

General Dynamics

$207.58

-0.62 (-0.30%)

ITW

Illinois Tool Works

$172.75

-0.645 (-0.37%)

NSC

Norfolk Southern

$150.90

-0.57 (-0.38%)

BHGE

Baker Hughes

$35.81

0.26 (0.73%)

PGR

Progressive

$57.18

-1.04 (-1.79%)

RCL

Royal Caribbean

$127.33

-1.37 (-1.06%)

SWK

Stanley Black & Decker

$174.31

-0.92 (-0.53%)

ROK

Rockwell Automation

$206.01

2.075 (1.02%)

NTRS

Northern Trust

$107.43

0.94 (0.88%)

GWW

Grainger

$230.43

0.57 (0.25%)

ROL

Rollins

$47.90

0.02 (0.04%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Jan

  • 24

    Jan

  • 24

    Jan

  • 24

    Jan

  • 24

    Jan

  • 24

    Jan

  • 24

    Jan

  • 24

    Jan

  • 24

    Jan

  • 24

    Jan

  • 24

    Jan

  • 24

    Jan

  • 24

    Jan

  • 08

    Feb

  • 16

    Feb

  • 02

    Mar

  • 23

    Apr

  • 17

    May

TXN

Texas Instruments

$119.44

2.61 (2.23%)

, COF

Capital One

$105.09

-0.4 (-0.38%)

13:59
01/23/18
01/23
13:59
01/23/18
13:59
Earnings
Notable companies reporting after market close »

Notable companies…

TXN

Texas Instruments

$119.44

2.61 (2.23%)

COF

Capital One

$105.09

-0.4 (-0.38%)

UAL

United Continental

$77.39

0.52 (0.68%)

TSS

TSYS

$83.64

-0.11 (-0.13%)

NAVI

Navient

$13.52

-0.08 (-0.59%)

CREE

Cree

$36.69

0.4 (1.10%)

FUL

H.B. Fuller

$55.11

0.22 (0.40%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Jan

  • 23

    Jan

  • 23

    Jan

  • 23

    Jan

  • 23

    Jan

  • 23

    Jan

  • 24

    Jan

  • 24

    Jan

  • 21

    Mar

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.